Minerals and Cancer

  • Raymond J. Shamberger


Only a few epidemiological studies have been conducted to determine the relationship between minerals and the incidence of cancer in humans. This is mainly due to the difficulty of identifying populations with significantly different intakes of the various minerals. In contrast, there have been numerous studies on the carcinogenic effects of many metals, administered at high doses to the animals parenterally. However, the results of these animal studies have shed little light on the potential carcinogenic risk from these elements in the amounts occurring naturally in the diet of humans.


Mammary Tumor Zinc Deficiency Zinc Level Sodium Selenite Selenium Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schroeder, H. A., Balassa, J. J., and Vinton, W. H. 1964. Chromium, lead, cadmium, nickel and titanium in mice: Effect on mortality, tumors and tissue levels. J. Nutr. 83: 239–250.PubMedGoogle Scholar
  2. 2.
    Schroeder, H. A., Mitchener, M., Balassa, J. J., Kanisawa, M., and Nason, A. P. 1968. Zirconium, niobium, antimony and fluorine in mice: Effect on growth, survival and tissue levels. J. Nutr. 95: 95–101.PubMedGoogle Scholar
  3. 3.
    Schroeder, H. A., and Mitchener, M. 1971. Scandium, chromium (VI), gallium, yttrium, rhodium, palladium and indium in mice: Effects on growth and life span. J. Nutr. 101: 1431–1438.PubMedGoogle Scholar
  4. 4.
    Schroeder, H. A., and Mitchener, M. 1972. Selenium and tellurium in mice: Effects on growth, survival and tumors. Arch. Environ. Health 24: 66–71.PubMedGoogle Scholar
  5. 5.
    Shamberger, R. J., and Rudolph, G. 1966. Protection against cocarcinogenesis by antioxi-dants. Experientia 22: 116.PubMedGoogle Scholar
  6. 6.
    Riley, J. F. 1968. Mast cells, cocarcinogenesis and anti-carcinognesis in the skin of mice. Experientia 15: 1237–1238.Google Scholar
  7. 7.
    Shamberger, R. J. 1970. Relationship of selenium to cancer. I. Inhibitory effect of selenium on carcinogenesis. J. Natl. Cancer Inst. 44: 931–936.PubMedGoogle Scholar
  8. 8.
    Shamberger, R. J. 1972. Increase of peroxidation in carcinogenesis, J. Nat. Cancer Inst. 48: 1491–1497.PubMedGoogle Scholar
  9. 9.
    Shamberger, R. J., Andreone, T. L., and Willis, C. E. 1974. Antioxidants and cancer. IV. Initiating activity of malonaldehyde as a carcinogen. J. Natl. Cancer Inst. 53: 1771–1773.PubMedGoogle Scholar
  10. 10.
    Clayton, C. C., and Baumann, C. A. 1949. Diet and azo dye tumors: Effect of diet during a period when the dye is not fed. Cancer Res. 9: 575–582.PubMedGoogle Scholar
  11. 11.
    Griffin, A. C., and Jacobs, M. M. 1977. Effects of selenium on azo dye hepatocarcinogenesis. Cancer Lett. 3: 177–181.PubMedGoogle Scholar
  12. 12.
    Daoud, A. H., and Griffin, A. C. 1980. Effect of retinoic acid, butylated hydroxytoluene, selenium and sorbic acid on azo-dye hepatocarcinogenesis. Cancer Lett. 9: 299–304.PubMedGoogle Scholar
  13. 13.
    Balanski, R. M., and Hadsiolov, D. H. 1979. Influence of sodium selenite on the hepatocarcinogenic action of diethylnitrosamine in rats. Comptes Rendus Acad. Bulg. Sci. 32: 697–698.Google Scholar
  14. 14.
    Dzhoiev, F. D. 1978. Effect of selenium, phenobarbital, teturam, and carbon tetrachloride on the carcinogenic effect of diethylnitrosamine and 1,2-dimethylhydrazine. in G. O. Loogna (Ed.) Kantserog N-Nitrozonsoedin: Deistvie, Obraz., Opred., Mater Simp., 3rd Tallinn, USSR, pp. 51-53.Google Scholar
  15. 15.
    Harr, J. R., Exon, J. H., Weswig, P. H., and Whanger, P. D. 1973. Relationship of dietary selenium concentration; chemical cancer induction; and tissue concentration of selenium in rats. Clin. Toxicol. 8: 487–495.Google Scholar
  16. 16.
    Harr, J. R., Exon, J. H., Whanger, P. D., and Weswig, P. H. 1972. Effect of dietary selenium on N-2 fluorenyl-acetamide (FAA)-induced cancer in vitamin E supplemented, selenium depleted rats. Clin. Toxicol. 5: 187–194.PubMedGoogle Scholar
  17. 17.
    Marshall, M. V., Arnott, M. S., Jacobs, M. M, and Griffin, A. C. 1979. Selenium effects on the carcinogenicity and metabolism of 2-acetylaminofluorene. Cancer Lett. 7: 331–338.PubMedGoogle Scholar
  18. 18.
    Lotliker, P. D., Enomoto, M., Miller, J. A., and Miller, E. C. 1967. Species variations in the N-and ring-hydroxylation of 2-acetylaminofluorene and effects of 3-methylcholanthrene pretreatment. Proc. Soc. Exp. Biol. Med. 125: 341–346.Google Scholar
  19. 19.
    Lotliker, P. D., Hong, Y. S., and Baldy, W. L. 1978. Effects of 3-methylcholanthrene pretreatment on 2-acetylaminofluorene N-and ring-hydroxylation by rat and hamster liver microsomes. Toxicol. Lett. 2: 135–139.Google Scholar
  20. 20.
    Rasco, M. A., Jacobs, M. M., and Griffin, A. C. 1977. Effects of selenium on aryl hydrocarbon hydroxylase activity in cultured human lymphocytes. Cancer Lett. 3: 295–301.Google Scholar
  21. 21.
    Wortzman, M. S., Besbris, H. J., and Cohen, A. M. 1980. Effect of dietary selenium on the interaction between 2-acetylaminofluorene and rat liver DNA in vivo. Cancer Res. 40: 2610–2676.Google Scholar
  22. 22.
    Besbris, H. J., Wortzman, M. S., and Cohen, A. M. 1982. Effect of dietary selenium on the metabolism and excretion of 2-acetylaminofluorene in the rat. J. Toxicol. Environ. Heath 9: 63–76.Google Scholar
  23. 23.
    Chen, J., Goetchius, M. P., Combs, G. F., and Campbell, T. C. 1982. Effects of dietary selenium and vitamin E on covalent binding of aflatoxin to chick liver cell macromolecules. J. Nutr. 112: 350–355.PubMedGoogle Scholar
  24. 24.
    Lalor, J. H., and Llewellyn, G. C. 1981. Biointeraction of sodium selenite and aflatoxin B1 in the mongolian gerbil. J. Toxicol. Environ. Health 8: 387–400.PubMedGoogle Scholar
  25. 25.
    Jacobs, M. M., Jansson, B., and Griffin, A. C., 1977. Inhibitory effects of selenium on 1,2-dimethylhydrazine and methylazoxymethanol acetate induction of colon tumors. Cancer Lett. 2: 133–138.PubMedGoogle Scholar
  26. 26.
    Jacobs, M. M., Forst, C. F., and Beams, F. A. 1981. Biochemical and clinical effects of selenium on dimethylhydrazine-induced colon cancer in rats. Cancer Res. 41: 4458–4465.PubMedGoogle Scholar
  27. 27.
    Ankerst, J., and Sjorgren, H. O. 1982. Effect of selenium on the induction of breast fibroadenomas by adenovirus type 9 and 1,2-dimethylhydrazine-induced bowel carcinogenesis in rats. Int. J. Cancer 29: 707–710.PubMedGoogle Scholar
  28. 28.
    Soullier, B. K., Wilson, P. S., and Nigro, N. D. 1981. Effect of selenium on azoxymethane-induced intestinal cancer in rats fed high fat diet. Cancer Lett. 12: 343–348.PubMedGoogle Scholar
  29. 29.
    Harbach, P. R., and Swenberg, J. A. 1981. Effects of selenium on 1,2-dimethylhydrazine metabolism and DNA alkylation. Carcinogenesis 2: 575–580.PubMedGoogle Scholar
  30. 30.
    Banner, W. P., Tan, Q. H., and Zadeck, S. 1981. Studies of the mechanism by which selenium inhibits tumor formation. Proc. Am. Assoc. Cancer Res. 22: 115.Google Scholar
  31. 31.
    Schrauzer, G. N., and Ishmael, D. 1974. Effects of selenium and of arsenic on the genesis of spontaneous mammary tumors in inbred C3H mice. Ann. Clin. Lab. Sci. 4: 411–447.Google Scholar
  32. 32.
    Schrauzer, G. N., White, D. A., and Schneider, C. J. 1976. Inhibition of the genesis of spontaneous mammary tumors in C3H mice: Effects of selenium and of selenium antagonistic elements and their possible role in human breast cancer, Bioinorg. Chem. 6: 265–210.PubMedGoogle Scholar
  33. 33.
    Schrauzer, G. N., White, D. A., and Schneider, C. J. 1978. Selenium and cancer: Effects of selenium and of the diet on the genesis of spontaneous mammary tumors in virgin inbred female C3H/St mice. Bioinorg. Chem. 8: 387–396.PubMedGoogle Scholar
  34. 34.
    Wester, P. O., Brune, D., and Nordberg, G. 1981. Arsenic and selenium in lung, liver and kidney tissue from dead smelter workers, Br. J. Indust. Med. 38: 179–184.Google Scholar
  35. 35.
    Shamberger, R. J., and Bratush, C. M. 1980. Cadmium, selenium and zinc levels in kidneys. Trace Sub. Environ. Health Hemphill, D. D., (ed.), Univ. Missouri, Columbia XIV: 203–210.Google Scholar
  36. 36.
    Schrauzer, G. N., Kuehn, K., and Hamm, D. 1981. Effects of dietary selenium and lead on the genesis of spontaneous mammary tumors in mice. Biol. Trace Elem. Res. 3: 185–196.Google Scholar
  37. 37.
    Schrauzer, G. N., McGinness, J. E., and Kuehn, K. 1980. The effects of temporary selenium supplementation on the genesis of spontaneous mammary tumors in inbred female C3H/St. mice. Carcinogenesis 1: 199–201.PubMedGoogle Scholar
  38. 38.
    Thompson, H. J., and Becci, P. J. 1980. Selenium inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis in the rat. J. Natl. Cancer Inst. 65: 1299–1301.PubMedGoogle Scholar
  39. 39.
    Thompson, H. J., Meeker, L. D., and Becci, P. J. 1981. Effect of combined selenium and retinyl acetate treatment on mammary carcinogenesis. Cancer Res. 41: 1413–1416PubMedGoogle Scholar
  40. 40.
    Thompson, H. J., and Tagliaferro, A. R. 1980. Effect of selenium on 7,12-dimethylbenzan-thracene-induced mammary tumorigenesis. Fed. Proc. 39: 1117.Google Scholar
  41. 41.
    Thompson, H. J., Meeker, L. D., Becci, P. J., and Kokoska, S. 1982. Effect of short-term feeding of sodium selenite on 7,12-dimethylbenzanthracene-induced mammary carcinogenesis in the rat. Cancer Res. 42: 4954–4958.PubMedGoogle Scholar
  42. 42.
    Ip, C., and Sinha, D. K. 1981. Enhancement of mammary tumorigenesis by dietary selenium deficiency in rats with a high polyunsaturated diet. Cancer Res. 41: 31–34.PubMedGoogle Scholar
  43. 43.
    Ip, C. 1981. Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenzanthracene-induced mammary tumorigenesis in rats. Cancer Res. 41: 2683–2686.PubMedGoogle Scholar
  44. 44.
    Ip, C., 1981. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Cancer Res. 41: 4386–4390.PubMedGoogle Scholar
  45. 45.
    Spallholz, J. E., Martin, J. L., Gerlach, M. L., and Heizerling, R. H. 1975. Injectable selenium: Effect on the primary immune response of mice. Proc. Soc. Exp. Biol. Med. 148: 37–40.PubMedGoogle Scholar
  46. 46.
    Bradley, C. J., Kledzik, G. S., and Meites, J. 1976. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development. Cancer Res. 36: 319–324.PubMedGoogle Scholar
  47. 47.
    Ip, C., and Ip, M. M. 1981. Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vitamin A. Carcinogenesis 2: 915–918.PubMedGoogle Scholar
  48. 48.
    Young, E. O., and Milner, J. A. 1981. Inhibition of 7, 12-dimethylbenzanthracene-induced mammary tumors by selenium. Fed. Proc. 40: 949.Google Scholar
  49. 49.
    Welsch, C. W., Goodrich-Smith, M., Brown, C. K., Greene, H. D., and Hamel, E. J. 1981. Selenium and the genesis of murine mammary tumors. Carcinogenesis 2: 519–522.PubMedGoogle Scholar
  50. 50.
    Medina, D., and Shepherd, F. 1981. Selenium-mediated inhibition of 7, 12-dimethylbenzanthracene-induced mouse mammary tumorigenesis. Carcinogenesis 2: 451–455.PubMedGoogle Scholar
  51. 51.
    Birt, D. F., Lawson, T. A., Julius, A. D., Runice, C. E., and Saimasi, S. 1982. Inhibition by dietary selenium of colon cancer induced in the rat by bis(2-oxopropyl)nitrosamine. Cancer Res. 42: 4455–4459.PubMedGoogle Scholar
  52. 52.
    Thompson, H. J., and Becci, P. J. 1979. Effect of graded dietary levels of selenium on tracheal carcinomas induced by 1-methyl-1-nitrosourea. Cancer Lett. 7: 215–219.PubMedGoogle Scholar
  53. 53.
    O’Conner, T. P., Youngman, L. D., and Campbell, T. C. 1983. Effect of selenium on development of L-azaserine (Aza) induced preneoplastic abnormal acinar cell nodules (AACN) in rat pancreas. Fed. Proc. 42: 670.Google Scholar
  54. 54.
    Baldwin, S., Parker, R. S., and Misslbeck, N. 1983. Effect of dietary fat and selenium on the development of preneoplastic lesions in rat liver. Fed. Proc. 42: 1312.Google Scholar
  55. 55.
    LeBoeuf, R. A., Laishes, B. A., and Hoekstra, W. G. 1983. Effect of dietary selenium concentration on the early post-initiation stages of hepatocarcinogenesis. Fed. Proc. 42: 669.Google Scholar
  56. 56.
    Chatterjee, M., and Banerjee, M. R. 1982. Selenium mediated dose-inhibition of 7,12-dimethylbenzanthracene-induced transformation of mammary cells in organ culture. Cancer Lett. 17: 187–195.PubMedGoogle Scholar
  57. 57.
    Witting, C., Witting, U., and Krieg, V. 1982. The tumor-protective effect of selenium in an experimental model. J. Cancer Res. Clin. Oncol. 104: 109–113.PubMedGoogle Scholar
  58. 58.
    Abdullaev, G. B., Gasanov, G. G., Ragimov, R. N., Teplyakova, G. V., Mekhtiev, M. A., and Dzhafarov, A. I. 1973. Selenium and tumor growth under experimental conditions. Dokl. Akad. Nauk Azerb. SSR 29: 18–24.Google Scholar
  59. 59.
    Poirier, K. A., and Milner, J. A. 1979. The effect of various seleno-compounds on Ehrlich ascites tumor cells. Biol. Trace Elem. Res. 1: 25–34.Google Scholar
  60. 60.
    Greeder, G. A., and Milner, J. A. 1980. Factors influencing the inhibitory effect of selenium on mice inoculated with Ehrlich ascites tumor cells. Science 209: 825–827.PubMedGoogle Scholar
  61. 61.
    Whanger, P. D., and Weswig, P. H. 1975. Effects of selenium, chromium, and anti-oxidants on growth, eye cataracts, plasma cholesterol, and blood glucose in selenium deficient, vitamin A supplemented rats. Nutr. Rep. Int. 12: 345–357.Google Scholar
  62. 62.
    Mautner, H. G., and Jaffe, J. J. 1958. The activity of 6-selenopurine and related compounds against some experimental mouse tumors. Cancer Res. 18: 294–298.PubMedGoogle Scholar
  63. 63.
    Milner, J. A., and Hsu, C. Y. 1981. Inhibitory effects of selenium on the growth of L1210 leukemic cells. Cancer Res. 41: 1652–1656.PubMedGoogle Scholar
  64. 64.
    Medina, D., and Oborn, C. J. 1981. Differential effects of selenium on the growth of mouse mammary cells in vitro. Cancer Lett. 13: 333–344.PubMedGoogle Scholar
  65. 65.
    Ip, C. 1981. Modification of mammary carcinogenesis and tissue peroxidation by selenium deficiency and dietary fat. Nutr. Cancer 2: 136–142.PubMedGoogle Scholar
  66. 66.
    Randleman, C. D. 1980. Inhibitory effects of selenium on induced rat ovarian tumors. BIOS 51: 86–89.Google Scholar
  67. 67.
    Jacobs, M. M., Shubik, P., and Feldman, R. 1980. Influence of selenium on vascularization in the hamster cheek pouch. Cancer Lett. 9: 353–357.PubMedGoogle Scholar
  68. 68.
    Exon, J. H., Roller, L. D., and Elliott, S. C. 1976. Effect of dietary selenium on tumor induction by an oncogenic virus. Clin. Toxicol. 9: 273–279.PubMedGoogle Scholar
  69. 69.
    Watson-Williams, E. 1920. The treatment of inoperable cancer with selenium. Br. J. Surg. 8: 50–58.Google Scholar
  70. 70.
    Prowse, W. B. 1937. Carcinoma of breast with wide-spread metastases. Two cases of recovery. Br. Med. J. 1: 1021–1023.PubMedGoogle Scholar
  71. 71.
    Gillett, A. S., and Wakeley, C. P. G. 1922. Selenium in the treatment of malignant disease. Br. J. Surg. 9: 532–539.Google Scholar
  72. 72.
    Shamberger, R. J., and Willis, C. E. 1971. Selenium distribution and human cancer mortality. CRC Crit. Rev. Clin. Lab. Sci. 2: 211–221.PubMedGoogle Scholar
  73. 73.
    Shamberger, R. J., Tytko, S. A., and Willis, C. E. 1976. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality. Arch. Environ. Health 31: 231–235.PubMedGoogle Scholar
  74. 74.
    Schrauzer, G. N., White, D. A., and Schneider, C. J. 1977. Cancer mortality correlation studies—III: Statistical associations with dietary selenium intakes. Bioinorg. Chem. 7: 23–24.PubMedGoogle Scholar
  75. 75.
    Schrauzer, G. N., White, D. A., and Schneider, C. J. 1977. Cancer mortality correlation studies—IV: Associations with dietary intakes and blood levels of certain trace elements, notably Se-antagonists. Bioinorg. Chem. 7: 35–56.PubMedGoogle Scholar
  76. 76.
    Jansson, B., and Jacobs, M. M. 1976. Selenium—a possible inhibitor of colon and rectum cancer. in Proceedings of the symposium on selenium—tellurium in the environment. pp. 326–340. Pittsburgh: Industrial Health Foundation.Google Scholar
  77. 77.
    Bogden, J. B., Kemp, F. W., Buse, M., Thind, I. S., Louria, D. B., Forgacs, J., Llanos, G., and Terrones, I. M. 1981. Composition of tobaccos from countries with high and low incidence of lung cancer. I. Selenium, Polonium-210, Alternaria, tar and nicotine. J. Natl. Cancer Inst. 66: 27–31.PubMedGoogle Scholar
  78. 78.
    Shamberger, R. J., Rukovena, E., Longfield, A. K., Tytko, S. A., Deodhar, S., and Willis, C. E. 1973. Antioxidants and cancer. I. Selenium in the blood of normals and cancer patients. J. Natl. Cancer Inst. 50: 863–870.PubMedGoogle Scholar
  79. 79.
    Dickson, R. C., and Tomlinson, R. H. 1967. Selenium in blood and human tissues. Clin. Chem. Acta 16: 311–321.Google Scholar
  80. 80.
    McConnell, K. P., Broghamer, W. L., Blotcky, A. J., and Hurt, O. J. 1975. Selenium levels in human blood and tissues in health and in disease. J. Nutr. 105: 1026–1031.PubMedGoogle Scholar
  81. 81.
    Broghamer, W. L., McConnell, K. P., and Blotcky, A. J. 1976. Relationship between serum selenium levels and patients with carcinoma. Cancer 37: 1384–1388.PubMedGoogle Scholar
  82. 82.
    McConnell, K. P., Jagar, R. M., Higgins, P. J., and Blotcky, A. J. 1977. Serum selenium levels in patients with and without breast cancer. in J. Van Eys, M. S. Seelig, and B. L. Nichols (Eds.) Proceedings of the 18th meeting of the American College of Nutrition. Houston, Texas. pp. 195–198. New York: S. P. Medical and Scientific Books.Google Scholar
  83. 83.
    McConnell, K. P., Jager, R. M., Bland, K. I., and Blotcky, A. J. 1980. The relationship of dietary selenium and breast cancer. J. Surg. Oncol. 15: 67–70.PubMedGoogle Scholar
  84. 84.
    Capel, I. D., and Williams, D. C. 1979. Selenium and glutathione peroxidase in breast cancer. Obstet. Gynecol. 7: 425.Google Scholar
  85. 85.
    Broghamer, W. L., McConnell, K. P., Grimaldi, M., and Blotcky, A. J. 1978. Serum selenium and reticuloendothelial tumors. Cancer 41: 1462–1466.PubMedGoogle Scholar
  86. 86.
    Calautti, P., Moschini, G., Stievano, B. M., Tomio, L., Calzavara, F., and Perona, G. 1980. Serum selenium levels in malignant lymphoproliferative diseases. Scand. J. Haematol. 24: 63–66.PubMedGoogle Scholar
  87. 87.
    Goodwin, W. J., Lane, H. W., Bradford, K., Marshall, M. V., Griffin, A. C., Geopfert, H., and Jesse, R. H. 1983. Selenium and glutathione peroxidase levels in patients with epidermoid carcinoma of the oral cavity and oropharynx. Cancer 51: 110–115.PubMedGoogle Scholar
  88. 88.
    Schrauzer, G. N., and Rhead, W. J. 1971. Interpretation of the methylene blue reduction test of human plasma and the possible protecting effect of selenium. Experientia 27: 1069–1071.PubMedGoogle Scholar
  89. 89.
    Schrauzer, G. N., Rhead, W. J., and Evans, G. A., 1973. Selenium and cancer: Chemical interpretation of a plasma “cancer test.” Bioinorg. Chem. 2: 329–340.Google Scholar
  90. 90.
    Robinson, M. F., Godfrey, P. J., Thomson, C. D., Rea, H. M., and van Rij, A. M. 1979. Blood selenium and glutathione peroxidase activity in normal subjects and in surgical patients with and without cancer in New Zealand. Am. J. Clin. Nutr. 32: 1477–1485.PubMedGoogle Scholar
  91. 91.
    Nelson, A. A., Fitzhugh, O. G., and Calvery, H. O. 1943. Liver tumors following cirrhosis caused by selenium in rats. Cancer Res. 3: 230–236.Google Scholar
  92. 92.
    Shapiro, J. R. 1972. Selenium and carcinogenesis: A review. Ann. NY Acad. Sci. 192: 215–219.PubMedGoogle Scholar
  93. 93.
    Volgarev, N. N., and Tscherkes, L. A. 1967. Further studies in tissue changes associated with sodium selenate. in O. H. Muth (Ed.) Symposium: Selenium in biomedicine. pp. 179–184. Westport, Connecticut: Avi.Google Scholar
  94. 94.
    Schroeder, H. A., and Mitchener, M. 1971. Selenium and tellurium in rats: Effects on growth, survival and tumors. J. Nutr. 101: 1531–1540.PubMedGoogle Scholar
  95. 95.
    Schroeder, H. A., and Mitchener, M. 1972. Selenium and tellurium in mice. Arch. Environ. Health 24: 66–71.PubMedGoogle Scholar
  96. 96.
    Harr, J. R., Bone, J. F., Tinsley, I. J., Weswig, P. H., and Yamamoto, R. S. 1967. Selenium toxicity in rats. II. Histopathology. in O. H. Muth (Ed.) Symposium: Selenium in biomedicine. pp. 153–178. Westport, Connecticut: Avi.Google Scholar
  97. 97.
    Seifter, J., Ehrlich, W. E., Hudgma, G., and Mueller, G. 1946. Thyroid adenomas in rats receiving selenium. Science 103: 762.Google Scholar
  98. 98.
    National Cancer Institute Carcinogenesis Test Program. 1980. Bioassay of selenium sulfide (gavage) for possible carcinogenicity. NIH Publ. NIH-80-1750, 130 pp.Google Scholar
  99. 99.
    Walker, G. W. R., and Ting, K. P. 1967. Effect of selenium on recombination in barley. Can. J. Genet. Cytol. 9: 314–320.PubMedGoogle Scholar
  100. 100.
    Nickerson, W. J., Taber, W. A., and Falcone, G. 1956. Physiological basis of morphogenesis in fungi. 5. Effect of selenite and tellurite on cellular division of yeastlike fungi. Can. J. Microbiol. 2: 575–584.PubMedGoogle Scholar
  101. 101.
    Ahmed. Z. U., and Walker, G. W. R. 1975. The effects of urethane, sodium monohydrogen arsenate and selenocystine on crossing-over in Drosophilia melanogaster. Can. J. Genet. Cytol. 17: 55–66.PubMedGoogle Scholar
  102. 102.
    Jacobs, M. M., Matney, T. S., and Griffin, A. C. 1977. Inhibitory effects of selenium on the mutagenicity of 2-acetylaminofluroene (AAF) and AAF metabolites. Cancer Lett. 2: 319–322.PubMedGoogle Scholar
  103. 103.
    Shamberger, R. J., Corlett, C. L., Beaman, K. D., and Kasten, B. L. 1979. Antioxidants reduce the mutagenic effect of malonaldehyde and β-propiolactone, Part IX. Antioxidants and cancer. Mutat. Res. 66: 349–355.PubMedGoogle Scholar
  104. 104.
    Adams, G., Martin, S., and Milner, J. 1980. Effects of selenium on the Salmonella/microsome mutagen test system. Fed. Proc. 39: 790.Google Scholar
  105. 104a.
    Aherne, W., Piall, E., and Marks, V. 1978. Radioimmunoassay of methotrexate: Use of 75Selabelled methotrexate. Ann. Clin. Biochem. 15: 331–334.PubMedGoogle Scholar
  106. 105.
    Martin, S. E., Adams, G. H., Schillaci, M., and Milner, J. A. 1981. Antimutagenic effects of selenium on acridine orange and 7,12-dimethylbenzanthracene in the Ames Salmonella/microsomal system. Mutat. Res. 82: 41–46.PubMedGoogle Scholar
  107. 106.
    Arciszewska, L. K., Martin, S. E., and Milner, J. A. 1982. The antimutagenic effect of selenium on dimethylbenzanthracene and metabolites in the Ames Salmonella/microsome system. Biol. Trace Element Res. 4: 259–267.Google Scholar
  108. 107.
    Schillaci, M., Martin, S. E., and Milner, J. A. 1982. The effects of dietary selenium on the biotransformation of 7,12-dimethylbenzanthracene. Mutat. Res. 101: 31–37.PubMedGoogle Scholar
  109. 108.
    Shamberger, R. J., Baughman, F. F., Kalchert, S. L., Willis, C. E., and Hoffman, G. C. 1973. Carcinogen-induced chromosomal breakage decreased by antioxidants. Proc. Natl. Acad. Sci. USA 70: 1461–1463.PubMedGoogle Scholar
  110. 109.
    Ray, J. H., Altenburg, L. C., and Jacobs, M. M. 1978. Effects of sodium selenite and methyl methanesulphonate or N-hydroxy-2-acetylaminofluorene co-exposure on sister chromatid exchange production in human whole blood cultures. Mutat. Res. 57: 359–368.PubMedGoogle Scholar
  111. 110.
    Morimoto, K., Iijima, S., and Koizumi, A. 1982. Selenite prevents the induction of sister-chromatid exchanges by methyl mercury and mercuric chloride in human whole-blood cultures. Mutat. Res. 102: 183–192.PubMedGoogle Scholar
  112. 111.
    Russell, G. R., Nader, C. J., and Patrick, E. J. 1980. Induction of DNA repair by some selenium compounds. Cancer Lett. 10: 75–81.PubMedGoogle Scholar
  113. 111b.
    Williams, G. M. 1978. Further improvements in the hepatocyte primary culture DNA repair test for carcinogens: Detection of carcinogenic biphenyl derivatives. Cancer Lett. 4: 69–75.PubMedGoogle Scholar
  114. 112.
    Lawson, T., and Birt, D. 1981. BOP induced damage of pancreas DNA and its repair in hamsters pretreated with selenium. Proc. Am. Assoc. Cancer Res. 22: 93.Google Scholar
  115. 113.
    Norppa, H., Westermarck, T., Laasonen, M., Knuutila, L., and Knuutila, S. 1980. Chromosomal effects of sodium selenite in vivo. I. Aberrations and sister chromatid exchanges in human lymphocytes. Hereditas 93: 93–96.PubMedGoogle Scholar
  116. 114.
    Norppa, H., Westermarck, T., Oksanen, A., Rimaila-Parnanen, E., and Knuutila, S. 1980. Chromosomal effects of sodium selenite in vivo. II. Aberrations in mouse bone marrow and primary spermatocytes. Hereditas 93: 97–99.PubMedGoogle Scholar
  117. 115.
    Kuhnlein, H. V., Levander, O. A., King, J. C., Sutherland, B., and Riskie, L. 1981. Dietary selenium and fecal mutagenicity in young men. Fed. Proc. 40: 903.Google Scholar
  118. 116.
    Rosin, M. P. 1981. Inhibition of spontaneous mutagenesis in yeast cultures by selenite, selenate, and selenide. Cancer Lett. 13: 7–14.PubMedGoogle Scholar
  119. 117.
    Nakamuro, K., Yoshikawa, K., Sayato, Y., Kurata, H., Tonomura, M., and Tonomura, A. 1976. Studies on selenium-related compounds. V. Cytogenetic effect and reactivity with DNA. Mutat. Res. 40: 177–184.PubMedGoogle Scholar
  120. 118.
    Kada, T., Tutikawa, K., and Sadaie, Y. 1972. In vitro and host mediated “rec assay” procedures for screening chemical mutagens, and phloxine, a mutagenic red dye detected. Mutat. Res. 16: 165–174.PubMedGoogle Scholar
  121. 119.
    Noda, M., Takano, T., and Sakurai, H. 1979. Mutagenic activity of selenium compounds. Mutat. Res. 66: 175–179.PubMedGoogle Scholar
  122. 120.
    Kanematsu, N., Hara, M., and Kada, T. 1980. Rec assay and mutagenicity studies on metal compounds. Mutat. Res. 77: 109–116.PubMedGoogle Scholar
  123. 121.
    Ray, J. H., and Altenburg, L. C. 1978. Sister-chromatid exchange induction by sodium selenite: Dependence on the presence of red blood cells or red blood cell lysate. Mutat. Res. 54: 343–354.PubMedGoogle Scholar
  124. 122.
    Sirianni, S. R., and Huang, C. C. 1983. Inductions of sister chromatid exchange by various selenium compounds in Chinese hamster cells in the presence and absence of S9 mixture. Cancer Lett. 18: 109–116.PubMedGoogle Scholar
  125. 123.
    Norppa, H., Westermarck, T., and Knuutila, S. 1980. Chromosomal effects of sodium selenite in vivo. III. Aberrations and sister chromatid exchanges in Chinese hamster bone marrow. Hereditas 93: 101–105.PubMedGoogle Scholar
  126. 124.
    Schwarz, K. 1976. Essentiality and metabolic functions of selenium. Med. Clin. North Am. 60: 745–758.PubMedGoogle Scholar
  127. 125.
    Lo, L. W., Koropatnick, J., and Stich, H. F. 1978. The mutagenicity and cytotoxicity of selenite, “activated” selenite and selenate for normal and DNA repair-deficient human fibro-blasts. Mutat. Res. 49: 305–312.PubMedGoogle Scholar
  128. 126.
    Lofroth, G., and Ames, B. N. 1978. Mutagenicity of inorganic compounds in Salmonella typhimurium: Arsenic, chromium, and selenium. Mutat. Res. 53: 65–66.Google Scholar
  129. 127.
    Whiting, R. F., Wei, L., and Stich, H. F. 1980. Unscheduled DNA synthesis and chromosome aberrations induced by inorganic and organic selenium compounds in the presence of glutathione. Mutat. Res. 78: 159–169.PubMedGoogle Scholar
  130. 128.
    Hsieh, H. S., and Ganther, H. E. 1975. Acid-volatile selenium formation catalyzed by glutathione reductase. Biochemistry 14: 1632–1636.PubMedGoogle Scholar
  131. 129.
    Schut, H. A. J., and Thorgeirsson, S. S. 1979. Mutagenic activation of N-hydroxy-2-acetylaminofluorene by developing epithelial cells of rat small intestine and effects of antioxidants. J. Natl. Cancer Inst. 63: 1405–1409.PubMedGoogle Scholar
  132. 130.
    Tkeshelashvili, L. K., Shearman, C. W., Zakour, R. A., Koplitz, R. M., and Loeb, L. A. 1980. Effects of arsenic, selenium, and chromium on the fidelity of DNA. Cancer Res. 40: 2455–2460.PubMedGoogle Scholar
  133. 131.
    Berenshtein, T. F. 1972. Effect of selenium and vitamin E on antibody formation in rabbits. Zdrawookhr Boloruss 18: 34–41.Google Scholar
  134. 132.
    Spallholz, J. E., Martin, J. L., Gerlach, M. L., and Heinzerling, R. H. 1973. Immunological responses of mice fed diets supplemented with selenite selenium. Proc. Soc. Exp. Biol. Med. 143: 685–689.PubMedGoogle Scholar
  135. 133.
    Spallholz, J. E., Martin, J. L., Gerlach, M. L., and Heizerling, R. H. 1973. Enhanced IgM and IgG titers in mice fed selenium. Infect. Immun. 8: 841–842.Google Scholar
  136. 134.
    Spallholz, J. E., Heinzerling, R. H., Gerlach, M. L., and Martin, J. L. 1974. The effects of selenite, tocopherol acetate and selenite, tocopherol acetate on the primary and secondary immune responses of mice administered tetanus toxoid or sheep red blood cell antigen. Fed. Proc. 33: 694.Google Scholar
  137. 135.
    Norman, B. B., and Johnson, W. 1976. Selenium responsive disease. Anim. Nutr. Health 31: 6.Google Scholar
  138. 136.
    Aleksondrovicz, J. 1977. Effects of food enrichment with various doses of sodium selenite on some immune response in laboratory animals. Rocz. Nauk. Zootech. 4: 113–126.Google Scholar
  139. 137.
    Shakelford, J., and Martin, J. 1980. Antibody response of mature male mice after drinking water supplemented with selenium. Fed. Proc. 39: 339.Google Scholar
  140. 138.
    Koller, L. D., Issacson-Kerkvliet, N., Exon, J. H., Brauner, J. A., and Patton, N. M. 1979. Synergism of methylmercury and selenium producing enhanced antibody formation in mice. Arch. Environ. Health 34: 248–251.PubMedGoogle Scholar
  141. 139.
    Marsh, J. A., Dietert, R. R., and Combs, G. F. 1981. Influence of dietary selenium and vitamin E on the humoral immune response of the chick. Proc. Soc. Exp. Biol. Med. 166: 228–236.PubMedGoogle Scholar
  142. 140.
    Sheffy, B. E., and Schultz, R. D. 1978. Influence of vitamin E and selenium on immune response mechanisms. Cornell Vet. 68 (Supp1. 7): 89–93.Google Scholar
  143. 141.
    Martin, J. L., and Spallholz, J. E. 1977. Selenium in the immune response. pp. 204–225. in Proceedings of a Symposium on selenium-Tellurium in the environment. Pittsburgh: Industrial Health Foundation.Google Scholar
  144. 142.
    Serfass, R. E., and Ganther, H. E. 1975. Defective microcidal activity in glutathione perox-idase deficient neutrophils of selenium-deficient rats. Nature 255: 640.PubMedGoogle Scholar
  145. 143.
    Boyne, R., and Arthur, J. R. 1979. Alterations of neutrophil functions in selenium deficient cattle. J. Comp. Pathol. 89: 151–158.PubMedGoogle Scholar
  146. 144.
    Berenshtein T. F. 1973. Stimulation of a nonspecific immunity in immunized rabbits by sodium selenite. Ser. Biyal Navek 1: 87–89.Google Scholar
  147. 145.
    Behrenstein, T. F. 1975. Change in the immunological response of vaccinated rabbits following the administration of selenium and vitamin A. Selen. Biol. Mater. Nauchen. Konf. 1: 94–96.Google Scholar
  148. 146.
    Berenshtein, T. F., and Zdravoukhi, C. G. 1976. Stimulation of the activity of nonspecific immunity factors by biological bases of molybdenum and selenium. Belowes 3: 67–68.Google Scholar
  149. 147.
    Desowitz, R. S., and Barnwell, J. W. 1980. Effect of dimethyl dioctadecyl ammonium bromide on the vaccine-induced immunity of Swiss-Webster mice against malaria (Plasmodium berghei). Infect. Immun. 27: 87–89.PubMedGoogle Scholar
  150. 148.
    Mulhern, S. A., Morris, V. C., Vessey, A. R., and Levander, O. A. 1981. Influence of selenium and chow diets on immune function in first and second generation mice. Fed. Proc. 40: 935.Google Scholar
  151. 149.
    Golden, M. H. N., Golden, B. E., Harland, P. S. E., and Jackson, A. A. 1978. Zinc and immunocompetence in protein-energy malnutrition. Lancet 1: 1226–1227.PubMedGoogle Scholar
  152. 150.
    Stocks, P., and Davies, R. I. 1964. Zinc and copper content of soils associated with the incidence of cancer of the stomach and other organs. Br. J. Cancer 18: 14–24.PubMedGoogle Scholar
  153. 151.
    Schrauzer, G. N., White, D. A., and Schneider, C. J. 1977. Cancer mortality correlation studies. IV. Associations with dietary intakes and blood levels of certain trace elements, notably Se-antagonists. Bioinorg. Chem. 7: 35–56.PubMedGoogle Scholar
  154. 152.
    Van Rensburg, S. J. 1981. Epidemiologic and dietary evidence for a specific nutritional predisposition to esophageal cancer. J. Natl. Cancer Inst. 67: 243–251.PubMedGoogle Scholar
  155. 153.
    Issell, B. F., MacFadyen, B. V., Gum, E. T., Valdivieso, M., Dudrick, S. J., and Bodey, G. P. 1981. Serum zinc levels in lung cancer patients. Cancer 47: 1845–1848.PubMedGoogle Scholar
  156. 154.
    Davies, I. J., Musa, M., and Dormandy, T. L. 1968. Measurements of plasma zinc. I. In health and disease. J. Clin. Pathol. 21: 359–365.PubMedGoogle Scholar
  157. 155.
    Strain, W. H., Mansour, E. G., Flynn, A., Pories, W. J., Tomaro, A. J., and Hill, O. A. 1972. Plasma-zinc concentrations in patients with bronchogenic cancer. Lancet 1: 1021–1022.PubMedGoogle Scholar
  158. 156.
    Fisher, G. L., Byers, V. S., Shifrine, M., and Levin, A. S. 1976. Copper and zinc levels in serum from human patients with sarcomas. Cancer 37: 356–363.PubMedGoogle Scholar
  159. 157.
    Lin, H. J., Chan, W. C., Fong, Y. Y., and Newberne, P. M. 1977. Zinc levels in serum, hair and tumors from patients with esophageal cancer. Nutr. Rep. Int. 15: 635–643.Google Scholar
  160. 158.
    Gyorkey, F., Min, K. W., Huff, J. A., and Gyorkey, P. 1967. Zinc and magnesium in human prostate gland: Normal, hyperplastic and neoplastic. Cancer Res. 27: 1348–1353.PubMedGoogle Scholar
  161. 159.
    Griffith, K., Wright, E. B., and Dormandy, T. L. 1973. Tissue zinc in malignant disease. Nature 241: 60.PubMedGoogle Scholar
  162. 160.
    Mulay, I. L., Roy, R., Knox, B. E., Suhr, N. H., and Delaney, W. E. 1971. Trace metal analysis of cancerous and noncancerous human tissue. J. Natl. Cancer Inst. 47: 1–11.PubMedGoogle Scholar
  163. 161.
    Kew, M. C., and Mallett, R. C. 1974. Hepatic zinc concentrations in primary cancer of the liver. Br. J. Cancer 29: 80–83.PubMedGoogle Scholar
  164. 162.
    Janes, J. M., McCall, J. T., and Elveback, I. R. 1972. Trace metals in human osteogenic sarcoma. Mayo Clin. Proc. 47: 476–478.PubMedGoogle Scholar
  165. 163.
    Olson, K. B., Meggen, G. E., and Edwards, C. F. 1958. Analysis of 5 trace elements in liver of patients dying of cancer and non-cancerous disease. Cancer 11: 554–561.PubMedGoogle Scholar
  166. 164.
    McBean, L. D., Dove, J. T., Halsted, J. A., and Smith, J. C. 1972. Zinc concentration in human tissues. Am. J. Clin. Nutr. 25: 672.PubMedGoogle Scholar
  167. 165.
    Shamberger, R. J. 1980. Cadmium, selenium and zinc levels in kidneys. in D. D. Hemphill (Ed.) Trace substances in environmental health. Univ. Missouri, Columbia XIV: 203–210.Google Scholar
  168. 166.
    Petering, H. G., Buskirk, H. H., and Crim, J. A. 1967. The effect of dietary mineral supplements of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicar-bazone). Cancer Res. 27: 1115–1121.PubMedGoogle Scholar
  169. 167.
    DeWys, W., Pories, W. J., Richter, M. C., and Strain, W. H. 1970. Inhibition of Walker 256 carcinosarcoma growth by dietary zinc deficiency. Proc. Soc. Exp. Biol. Med. 135: 17–22.PubMedGoogle Scholar
  170. 168.
    Minkel, D. T., Dolhun, P. J., Calhoun, B. L., Saryan, L. A., and Petering, D. H. 1979. Zinc deficiency and growth of Ehrlich ascites tumor. Cancer Res. 39: 2451–2456.PubMedGoogle Scholar
  171. 169.
    Duncan, J. R., Dreosti, I. E., and Albrecht, C. F. 1974. Zinc intake and growth of a transplanted hepatoma induced by 3-methyl-4-dimethylaminoazobenzene in rats. J. Natl. Cancer Inst. 53: 277–278.PubMedGoogle Scholar
  172. 170.
    Beach, R. S., Gershwin, M. E., and Hurley, L. S. 1981. Dietary zinc modulation of Moloney sarcoma virus oncogenesis. Cancer Res. 41: 552–559.PubMedGoogle Scholar
  173. 171.
    Barr, D. H., and Harris, J. W. 1973. Growth of P-388 leukemia as an ascites tumor in zinc deficient mice. Proc. Soc. Exp. Biol. Med. 144: 284–287.PubMedGoogle Scholar
  174. 172.
    Fenton, M. R., Burke, J. P., Tursi, F. D., and Arena, F. P. 1980. Effect of a zinc-deficient diet on the growth of an IgM-secreting plasmacytoma (TEPC-183). J. Natl. Cancer Inst. 65: 1271–1272.PubMedGoogle Scholar
  175. 173.
    Fong, L. Y. Y., Sivak, A., and Newberne, P. M. 1978. Zinc deficiency and methylbenzylni-trosamine-induced esophageal cancer in rats. J. Natl. Cancer Inst. 61: 145–150.PubMedGoogle Scholar
  176. 174.
    DeWys, W., and Pories, W. J. 1972. Inhibition of a spectrum of animal tumors by dietary zinc deficiency. Cancer Res. 48: 375–381.Google Scholar
  177. 175.
    Woster, A. D., Failla, M. L., Taylor, M. W., and Weinberg, E. D. 1975. Zinc suppression of initiation of sarcoma 180 growth. J. Natl. Cancer Inst. 54: 1001–1003.PubMedGoogle Scholar
  178. 176.
    Phillips, J. L., and Sheridan, P. J. 1976. Effect of zinc administration on the growth of L 1210 and BW 5147 tumors in mice. J. Natl. Cancer Inst. 57: 361–363.PubMedGoogle Scholar
  179. 177.
    Poswillo, D. E., and Cohen, B. 1971. Inhibition of carcinogenesis by zinc. Nature 231: 447–448.PubMedGoogle Scholar
  180. 178.
    Schrauzer, G. N. 1979. Trace elements in carcinogenesis. in H. H. Draper (Ed.) Advances in nutritional research. Vol. 2. pp. 219–244. New York: Plenum.Google Scholar
  181. 179.
    Verma, R., Jain, S., Arora, H. L., Sareen, P. M., Kalra, V. B., and Lodha, S. K. 1982. Protective efficacy of zinc supplementation on 20-MCA induced sarcomas: An experimental study in mice. Ind. J. Cancer 19: 126–130.Google Scholar
  182. 180.
    Beisel, W. R., Edelman, R., Nauss, K., and Suskind, R. M. 1981. Single-nutrient effects on immunologic functions. JAMA 245: 53–58.PubMedGoogle Scholar
  183. 181.
    Pekarek, R. 1980. Abnormal cellular immune response during acquired zinc deficiency. Am. J. Clin. Nutr. 32: 1466–1471.Google Scholar
  184. 182.
    Koller, L. D. 1980. Review/commentary—immunotoxicology of heavy metals. Int. J. Immunopharmacol. 2: 269–279.PubMedGoogle Scholar
  185. 183.
    DePasquale-Jardieu, P., and Fraker, P. J. 1979. The role of corticosterone in the loss in immune function in the zinc deficient A/J mouse. Fed. Proc. 38: 122.Google Scholar
  186. 184.
    Cunningham-Rundles, C., Cunningham-Rundles, S., Garofalo, J., Dupont, B., and Good, R. A. 1979. The effect of zinc on human B-cell activation. Fed. Proc. 38: 1222.Google Scholar
  187. 185.
    Duchateau, J., Delesphesse, G., and Vereecke, P. 1981. Influence of oral zinc supplementation on the lymphocyte response to mitogens of normal subjects. Am. J. Clin. Nutr. 34: 88–93.PubMedGoogle Scholar
  188. 186.
    Good, R. A., Fernandes, G., and West, A. 1979. Nutrition, immunity and cancer—a review (Part 1). Clin. Bull. 9: 1–12.Google Scholar
  189. 187.
    White, J. R., Yeowell, H. N., and Dearman, H. H. 1981. Role of transition metals in the bactericidal action of streptonigrin. Bioenergetics IV: 1500–1501.Google Scholar
  190. 188.
    Schrauzer, G. N., White, D. A., and Schneider, G. J. 1977. Cancer mortality correlations studies—IV. Associations with dietary intakes and blood levels of certain trace elements, notably Se-antagonists. Bioinorg. Chem. 7: 35–56.PubMedGoogle Scholar
  191. 189.
    Hrgovcic, M., Tessner, C. F., Minckler, T. M., Mosler, B., and Taylor, G. H. 1968. Serum copper levels in lymphoma and leukemia: Special reference to Hodgkin’s disease. Cancer 21: 743–755.PubMedGoogle Scholar
  192. 190.
    Hrgovcic, M., Tessmer, C. F., Thomas, F. B., Fuller, L. M., Gamble, J. F., and Shullenberg, C. C. 1973. Significance of serum copper levels in adult patients with Hodgkins’s disease. Cancer 31: 1337–1345.PubMedGoogle Scholar
  193. 191.
    Wilimas, J., Thompson, E., and Smith, K. L. 1978. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin’s disease. Cancer 42: 1929–1935.PubMedGoogle Scholar
  194. 192.
    Schwartz, M. K. 1975. Role of trace elements in cancer. Cancer Res. 35: 3481–3487.PubMedGoogle Scholar
  195. 193.
    Delves, H., Alexander, F. W., and Lay, H. 1973. Copper and zinc concentrations in the plasma of leukaemic children. Br. J. Haematol. 24: 525–531.PubMedGoogle Scholar
  196. 194.
    Karcioglu, Z. A., Sarper, R. M., Van Rinsvelt, H. A., Guffey, J. A., and Fink, R. W. 1978. Trace element concentrations in renal cell carcinoma. Cancer 42: 1330–1340.PubMedGoogle Scholar
  197. 195.
    Fisher, G. L., Spitler, L. E., McNeill, K. L., and Rosenblatt, L. S. 1981. Serum copper and zinc levels in melanoma patients. Cancer 47: 1838–1844.PubMedGoogle Scholar
  198. 196.
    Roguljic, A., Mikac-Devic, D., and Krusic, J. 1980. Copper, zinc and magnesium levels in healthy tissues and benign and malignant tumors of the uterus. Periodicum Biologorum 82: 213–216.Google Scholar
  199. 197.
    Lefkowitch, J. H., Muschel, R., Price, J. B., Marboe, C., and Braunhut, S. 1983. Copper and copper-binding protein in fibrolamellar liver cell carcinoma. Cancer 51: 97–100.PubMedGoogle Scholar
  200. 198.
    Prohaska, J. R., and Lukasewycz, O. A. 1981. Copper deficiency supresses the immune response of mice. Science 213: 559–561.PubMedGoogle Scholar
  201. 199.
    Kamamoto, Y., Makiura, S., Sugihara, S., Hiasa, Y., Arai, M., and Ito, N. 1973. The inhibitory effect of copper on DL-ethionine carcinogenesis in rats. Cancer Res. 33: 1129–1135.PubMedGoogle Scholar
  202. 200.
    Yamane, Y., and Sakai, K. 1973. Supressive effect of concurrent administration of metal salts on carcinogenesis by 3-methyl-4-(dimethylamino)azobenzene, and the effect of these metals on aminoazo dye metabolism during carcinogenesis. Gann 64: 563–573.PubMedGoogle Scholar
  203. 201.
    Larsson, G. G., Sandstrom, A., and Westling, P. 1975. Relationship of Plummer-Vinson disease to cancer of the upper alimentary tract in Sweden. Cancer Res. 35: 3308–3316.PubMedGoogle Scholar
  204. 202.
    Broitman, S. A., Velez, H., and Vitale, J. J. 1981. A possible role of iron deficiency in gastric cancer in Columbia. Adv. Exp. Med. Biol. 91: 155–181.Google Scholar
  205. 203.
    Ruddell, W. S. J., Bone, E. S., Hill, M. J., and Walters, C. L. 1978. Pathogenesis of gastric cancer in pernicious anaemia. Lancet 1: 521–523.PubMedGoogle Scholar
  206. 204.
    Cole, P., and Goldman, M. B. 1975. Occupation. in J. F. Fraumeni (Ed.) Persons at high risk of cancer: An approach to cancer etiology and control. pp. 167–183. New York: Academic Press.Google Scholar
  207. 205.
    MacKinnon, A. E., and Bancewicz, J. 1973. Sarcoma after injection of intramuscular iron. Br. Med. J. 2: 277–279.PubMedGoogle Scholar
  208. 206.
    Armann, R. W., Muller, E., Bansky, J., Schuler, J., and Hacki, W. H. 1980. High incidence of extrahepatic carcinomas in idiopathic hemochromatosis. Scand. J. Gastroenterol. 15: 733–736.Google Scholar
  209. 207.
    Sweeney, G. D., Jones, K. G., Cole, F. M., Basford, D., and Krestynski, F. 1979. Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzop-dioxin. Science 204: 332–335.Google Scholar
  210. 208.
    Vitale, J. J., Broitman, S. A., Vavrousek-Jakuba, E., Rodday, P. W., and Gottlieb, L. S. 1978. The effects of iron deficiency and the quality and quantity of fat on chemically induced cancer. Adv. Exp. Med. Biol. 91: 229–242.Google Scholar
  211. 209.
    Brusick, D., Gletten, F., Jagannath, D. R., and Weeks, U., 1976. The mutagenic activity of ferrous sulfate for Salmonella typhimurium. Mutat. Res. 38: 386.Google Scholar
  212. 210.
    Joynson, D. H. M., Jacobs, A., Walker, D. M., and Dolby, A. E. 1972. Defect of cell-mediated immunity in patients with iron-deficiency anemia. Lancet 2: 1058–1059.PubMedGoogle Scholar
  213. 211.
    Yang, C. S. 1980. Research on esophageal cancer in China: A review. Cancer Res. 40: 2633–2644.PubMedGoogle Scholar
  214. 212.
    Burrell, R. J. W., Roach, W. A., and Shadwell, A. 1966. Esophageal cancer in the Bantu of the Transkei associated with mineral deficiency in garden plants. J. Natl. Cancer Inst. 36: 201–204.PubMedGoogle Scholar
  215. 213.
    Berg, J. W., Haenszel, W., and Devesa, S. S. 1973. Epidemiology of gastrointestinal cancer. in Seventh National Cancer Conference proceedings. pp. 459–464. Philadelphia: J. B. Lippincott.Google Scholar
  216. 214.
    Luo, X. M., Wei, H. J., Hu, G. G., Shang, A. L., Liu, Y. Y., Lu, S. M., and Yang, S. P. 1981. Molybdenum and esophageal cancer in China. Fed. Proc. 40: 928.Google Scholar
  217. 215.
    Kopf-Maier, P. 1979. Molybdocen-dichlorid als antitumor-Agens. Z. Naturforsch. 34c: 1174–1176.Google Scholar
  218. 216.
    Wei, H. J., Luo, X. M., Sproat, H. F., and Yang, S. P. 1983. Inhibitory effects of molybdenum on N-methyl-N-nitrosourea-indiced mammary carcinogenesis in female rats. Fed. Proc. 42: 670.Google Scholar
  219. 217.
    Stoner, G. D., Shimkin, M. B., Troxell, M. C., Thompson, T. L., and Terry, L. S. 1976. Test for carcinogenicity of metallic compounds by the pulmonary tumor response in strain A mice. Cancer Res. 36: 1744–1747.PubMedGoogle Scholar
  220. 218.
    Nishioka, W. 1975. Mutagenic activities of metal compounds in bacteria. Mutat. Res. 31: 185–189.PubMedGoogle Scholar
  221. 219.
    Wahner, H. W., Cuello, C., Correa, P., Uribe, L. F., and Gaitan, E. 1966. Thyroid carcinoma in an endemic goiter area, Cali, Columbia. Am. J. Med. 40: 58–66.PubMedGoogle Scholar
  222. 220.
    Williams, E. D., Doniach, I., Bjarnason, O., and Michie, W. 1977. Thyroid cancer in an iodide rich area. A histopathological study. Cancer 39: 215–222.PubMedGoogle Scholar
  223. 221.
    Clements, F. W. 1954. The relationship of thyrotoxicosis and carcinoma of the thyroid to endemic goitre. Med. J. Aust. 2: 894–897.PubMedGoogle Scholar
  224. 222.
    Pendergrast, W. J., Milmore, B. K., and Marcus, S. C. 1961. Thyroid cancer and thyrotoxicosis in the United States: Their relation to endemic goiter. J. Chron. Dis. 13: 22–28.PubMedGoogle Scholar
  225. 223.
    Bogardus, G. M., and Finley, J. W. 1961. Breast cancer and thyroid disease. Surgery 49: 461–468.Google Scholar
  226. 224.
    Stadel, B. V. 1976. Dietary idoine and risk of breast, endometrial, and ovarian cancer. Lancet 1: 890–891.PubMedGoogle Scholar
  227. 225.
    Edington, G. M. 1976. Dietary iodine and risk of breast, endometrial and ovarian cancer. Lancet 1: 1413–1414.PubMedGoogle Scholar
  228. 226.
    Waterhouse, J., Muir, C., Correa, P., and Powell, J. (Eds.) 1976. Cancer incidence in five continents. Vol. 3. IRAC Scientific Publication No. 15. Lyons, France: International Agency for Research on Cancer.Google Scholar
  229. 227.
    Aquino, T. I., and Eskin, B. A. 1972. Rat breast structure in altered iodine metabolism. Arch. Pathol. Lab. Med. 94: 280–285.Google Scholar
  230. 228.
    Eskin, B. A. 1978. Iodine and mammary cancer. Adv. Exp. Med. Biol. 91: 293–304.Google Scholar
  231. 229.
    Eskin, B. A., Jacobson, H. I., Bolmarcich, V., and Murray, J. A. 1976. Breast atypia in altered iodine states: Intracellular changes. Senologia 1: 51.Google Scholar
  232. 230.
    Doniach, I. 1958. Experimental induction of tumors of the thyroid by radiation. Br. Med. Bull. 14: 181–183.PubMedGoogle Scholar
  233. 231.
    Leach, R. M. 1971. Role of manganese in mycopolysaccharide metabolism. Fed. Proc. 30: 991–994.PubMedGoogle Scholar
  234. 232.
    Sunderman, F. W., McCully, K. S., Taubman, S. B., Alpass, P. R., Reid, M. C., and Rineheimer, L. A. 1980. Manganese inhibition of sarcoma induction by benzopyrene in rats. Carcinogenesis 1: 613–620.PubMedGoogle Scholar
  235. 233.
    Sunderman, F. W., Kasprzak, K. S., Law, T. J., Minghetti, P. P., Maeriza, R. M., Becker, N., Onkelinx, C., and Goldblatt, P. J. 1976. Effects of manganese on carcinogenicity and metabolism of nickel subsulfide. Cancer Res. 36: 1790–1800.PubMedGoogle Scholar
  236. 234.
    Rensburg, S. J., Bruyn, D. B., Schalkwyk, D. J., Sunderman, F. W., McCully, K. S., Trubman, S., Allpass, P., Reid, M., and Rinchimer, L. 1980. Manganese inhibition of carcinoma induction by benzopyrene in rats. Carcinogenesis 1: 613–620.Google Scholar
  237. 235.
    Yamane, Y., and Sakai, K. 1973. Suppressive effect of concurrent administration of metal salts on carcinogenesis by 3-methyl-4-dimethylaminoazobenzene, and the effect of these metals on aminoazo dye metabolism during carcinogenesis. Gann 64: 563–573.PubMedGoogle Scholar
  238. 236.
    Yiamouyiannis, J., and Burk, D. 1977. Fluoridation and cancer: Age-dependence of cancer mortality related to artificial fluoridation. Fluoride 10: 102–123.Google Scholar
  239. 237.
    Doll, R., and Kinlen, L. 1977. Fluoridation of water and cancer mortality in the USA. Lancet 1: 1300–1302.PubMedGoogle Scholar
  240. 238.
    Hoover, R. N., McKay, F. W., and Fraumeni, J. F. 1976. Fluoridated drinking water and the occurrence of cancer. J. Natl. Cancer Inst. 57: 757–768.PubMedGoogle Scholar
  241. 239.
    Erickson, J. 1978. Mortality in selected cities with fluroidated and non-fluoridated water supplies. N. Engl. J. Med. 295: 1112–1116.Google Scholar
  242. 240.
    Oldham, P. D., and Newell, O. J. 1977. Fluoridation of water supplies and cancer—A possible association? Appl. Stats 26: 125–135.Google Scholar
  243. 241.
    Taves, D. R. 1977. Fluoridation and cancer mortality. Origins of human cancer. Book A: Incidence of cancer in humans. Vol. 4. pp. 357–366. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.Google Scholar
  244. 242.
    Bois, P., Sandborn, E. B., and Messier, P. E. 1969. A study of thymic lymphosarcoma developing in magnesium-deficient rats. Cancer Res. 29: 763–775.PubMedGoogle Scholar
  245. 243.
    Averdunk, R., Bippus, P. H., Gunther, T., and Merker, H. J. 1982. Development and properties of malignant lymphoma induced by magnesium deficiency in rats. J. Cancer Res. Clin. Oncol. 104: 63–73.PubMedGoogle Scholar
  246. 244.
    Young, G. A., and Parsons, F. M. 1977. The effects of dietary deficiencies of magnesium and potassium on the growth and chemistry of transplanted tumors and the host tissues in the rat. Eur. J. Cancer 13: 103–113.PubMedGoogle Scholar
  247. 245.
    Mills, B. J., Higgins, P. J., Broghamer, W. L., and Lindeman, R. D. 1983. Magnesium depletion inhibits growth of established tumors. Fed. Proc. 42: 1312.Google Scholar
  248. 246.
    Yancey, R. S. 1980. Vitamins and trace elements in the etiology and treatment of cancer. Cancer Bull. 32: 177–179.Google Scholar
  249. 247.
    Merliss, R. R. 1971. Talc-treated rice and Japanese stomach cancer. Science 173: 1141–1142.PubMedGoogle Scholar
  250. 248.
    Stemmermann, G. N., and Kolonel, L. N. 1978. Talc-coated rice as a risk factor for stomach cancer. Am. J. Clin. Nutr. 31: 2017–2019.PubMedGoogle Scholar
  251. 249.
    O’Neill, C., Clarke, G., Hodges, G., Jordan, P., Newman, R., Pan, Q. Q., Liu, F. S., Ge, M., Chang, Y. M., and Toulson, E. 1982. Silica fragments from millet bran in mucosa surrounding oesophageal tumours in patients in northern China. Lancet 1: 1202–1206.PubMedGoogle Scholar
  252. 250.
    O’Neill, C., Hodges, G. M., Riddle, P. N., Jordan, P. W., Newman, R. H., Flood, R. J., and Toulson, E. C. 1980. A fine fibrous silica contaminant of flour in the high esophageal cancer areas of northeast Iran. Int. J. Cancer 26: 617–628.PubMedGoogle Scholar
  253. 251.
    Cramer, D. W., Welch, W. R., Scully, R. E., and Wojciechowski, C. A. 1982. Ovarian cancer and talc. A case-control study. Cancer 50: 372–376.PubMedGoogle Scholar

Copyright information

© Raymond J. Shamberger 1984

Authors and Affiliations

  • Raymond J. Shamberger
    • 1
  1. 1.The Cleveland Clinic FoundationClevelandUSA

Personalised recommendations